新生儿体外膜肺氧合治疗后的生存与发育结局:10年单中心经验
该回顾性队列研究纳入2006年1月至2016年1月在费城儿童医院新生儿/婴儿重症监护病房接受ECMO治疗的191名新生儿,按ECMO主要指征分为内科指征组(96例)与外科指征组(95例)。出院存活率为71%,内科指征组显著高于外科指征组(82% vs 60%;P = .001)。存活者发育治疗与神经感觉异常比例高,Bayley-III平均表现显著低于人群常模,外科组24月龄运动延迟比例高于内科组(49% vs 15%;P = .03)。
要点
- 内科指征ECMO患儿出院存活率显著高于外科指征患儿(82% vs 60%;P = .001)。
- 存活者Bayley-III平均得分显著低于人群常模,发育治疗与神经感觉异常比例高。
- 24月龄时外科指征组运动延迟比例高于内科组(49% vs 15%;P = .03)。
核心结论
- 新生儿ECMO外科指征患者较内科指征患者出院存活率更低、运动延迟发生率更高。
- 需要减少随访障碍并提高该高危人群出院后发育监测与干预率。
研究设计与样本
- 回顾性队列研究,纳入2006年1月至2016年1月费城儿童医院新生儿/婴儿重症监护病房接受ECMO治疗的新生儿。
- 共191名新生儿符合纳入标准,内科指征96例、外科指征95例;主要终点采用Bayley-III评估,组间比较用标准双变量检验与多变量回归。
主要发现
- 出院存活率为71%,内科指征组82%显著高于外科指征组60%(P = .001)。
- 存活者发育治疗与神经感觉异常比例高;12月龄发育结局数据可得66%,24月龄可得70%。
- Bayley-III平均表现显著低于预期人群常模值;外科患者随时间Bayley-III得分略低。
- 24月龄运动延迟:内科指征婴儿15%,外科指征婴儿49%(P = .03)。
关键数值与推荐
- ECMO主要指征分类为内科(如胎粪吸入综合征)或外科(如先天性膈疝)。
- 主要研究终点采用Bayley-III评估。
- 出院存活率71%;内科指征组82% vs 外科指征组60%(P = .001)。
- 24月龄运动延迟内科组15% vs 外科组49%(P = .03)。
临床怎么用
- 对新生儿ECMO存活者应重视出院后发育监测,尤其外科指征患儿运动延迟风险更高。
- 应关注随访可及性,减少随访障碍以提高发育评估与干预覆盖率。
局限性
- 为单中心回顾性队列研究,结论外推需谨慎。
- 12月龄发育结局数据仅66%可得、24月龄仅70%可得,存在随访缺失。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the associations between the primary indication for extracorporeal membrane oxygenation (ECMO) in neonates and neurodevelopmental outcomes at 12 and 24 months of age. STUDY DESIGN: This is a retrospective cohort study of neonates treated with ECMO between January 2006 and January 2016 in the Children's Hospital of Philadelphia newborn/infant intensive care unit. Primary indication for ECMO was classified as medical (eg, meconium aspiration syndrome) or surgical (eg, congenital diaphragmatic hernia). Primary study endpoints were assessed with the Bayley Scales of Infant and Toddler Development, Third Edition (Bayley-III). Groups were compared with standard bivariate testing and multivariable regression. RESULTS: A total of 191 neonates met the study's inclusion criteria, including 96 with a medical indication and 95 with a surgical indication. Survival to discharge was 71%, with significantly higher survival in the medical group (82% vs 60%; P = .001). Survivors had high rates of developmental therapies and neurosensory abnormalities. Developmental outcomes were available for 66% at 12 months and 70% at 24 months. Average performance on the Bayley-III was significantly below expected population normative values. Surgical patients had modestly lower the Bayley-III scores over time; most notably, 15% of medical infants and 49% of surgical infants had motor delay at 24 months (P = .03). CONCLUSIONS: In this single-center cohort, surgical patients had lower survival rates and higher incidence of motor delays. Strategies to reduce barriers to follow-up and improve rates of postdischarge developmental surveillance and intervention in this high-risk population are needed.
引用
- Kim F, Bernbaum J, Connelly J, et al. Survival and Developmental Outcomes of Neonates Treated with Extracorporeal Membrane Oxygenation: A 10-Year Single-Center Experience. J Pediatr. 2020. PMID: 33058857. doi:10.1016/j.jpeds.2020.10.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。